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ABSTRACT 
ALTERATIONS IN REGIONAL CEREBRAL BLOOD FLOW WITH PROPOFOL 
ANESTHESIA COMPARED WITH SEVOFLURANE.  Tejas Manchandia, Maolin Qiu, 
Margaret Rose, Todd Constable, and Ramachandran Ramani.  Department of 
Anesthesiology and Department of Diagnostic Radiology, Yale University School of 
Medicine, New Haven, CT.   
 
Alterations in regional cerebral blood flow (rCBF) are a reflection of neuronal activity in 
the brain because of the property of flow-metabolism coupling.  Our group has previously 
reported a non-uniformity in rCBF changes with 0.25 MAC sevoflurane.  The purpose of 
this project was to measure the alteration in rCBF with 0.5 MAC equivalent propofol and 
compare the changes in rCBF with those observed previously with sevoflurane.  We 
hypothesize that sevoflurane and propofol produce spatially non-uniform changes in 
rCBF, with significant decreases in the thalamus and prefrontal cortex.  The study 
protocol was approved by the Yale University Human Investigation Committee (HIC).  
The subjects were 30 healthy volunteers (19-35 years old).  Propofol was administered 
through a target controlled infusion (TCI) device to a target plasma concentration of 2 
µg/mL (0.5 MAC equivalent).  Propofol level was confirmed by drawing a blood sample 
at the beginning and end of the infusion period.  Regional CBF was measured in a 3 Tesla 
Siemens Trio scanner using the pulsed arterial spin labeling (PASL) technique.  CBF was 
measured in the subjects while awake and under anesthesia, and the difference was 
calculated (δCBF).  With 2 µg/mL plasma level propofol, there was a drop in rCBF in 
several areas of the frontal, parietal, occipital, and temporal cortices as well as the 
	  
thalamus.  Clinically, all the subjects were asleep and had no memory of the event.  A 
modest rise in rCBF was seen in the anterior cingulate, insula, and parahippocampal 
gyrus.  Our results support our hypothesis that propofol causes a non-uniformity in rCBF, 
which was observed with sevoflurane as well.  
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INTRODUCTION 
Although general anesthetic agents have been used extensively for over 160 years, 
their mechanism of action on brain physiology remains poorly understood.  The two main 
classes of general anesthetics are intravenous agents, such as propofol, and volatile 
agents, such as sevoflurane [1].  The primary goal in anesthesia is to induce amnesia, 
analgesia, hypnosis, muscle relaxation, and suppression of reflex motor response. 
Propofol, one of the most commonly used anesthetic agents, is a potent short-
acting intravenous agent used for induction and maintenance of general anesthesia [2].  
Despite being used widely for over 20 years, its exact functional target and neural 
mechanism remains unknown.  There have been several proposed mechanisms of action 
of propofol-induced anesthesia, including potentiation of γ-aminobutyric acid (GABA) 
receptor activity and acting as a sodium channel blocker [3, 4, 5].  Studies have also 
shown that propofol interacts with and influences the release of various other 
neurotransmitters, including glycine, acetylcholine, glutamate, and serotonin, with 
concentrations varying in different regions of the brain following propofol-induced 
anesthesia [6, 7].  However, the most accepted theory is that propofol produces its effects 
by positive modulation of the agonist effects of GABA at the GABAA receptor level, as 
opposed to effects occurring at the axonal pathway [6, 8, 9]. 
In contrast, sevoflurane is an inhaled agent used for induction and maintenance of 
general anesthesia with a rapid onset and offset of action.  It acts on many areas in the 
CNS, but its precise mechanism of action also remains unknown.  Some areas that play a 
role in consciousness and are likely suppressed by sevoflurane and other inhaled 
anesthetic agents include the cerebral cortex, thalamus, limbic system and reticular 
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formation [10].  In terms of its mechanism of action, it is widely believed that 
sevoflurane potentiates inhibitory postsynaptic channel activity at GABAA and glycine 
receptors, as well as inhibits excitatory postsynaptic channel activity at nicotinic 
acetylcholine, serotonin, and glutamate receptors [8].  However, there is no definitive 
evidence as to its exact targets in the brain or its neural mechanism. 
 Recent advancements within the field of brain imaging offers great potential to 
better understand the mechanism of these anesthetic agents [11].  The two most common 
and most powerful imaging techniques used to study human brain activation are positron 
emission tomography (PET) and functional magnetic resonance imaging (fMRI), which 
are both capable of mapping regional changes in cerebral blood flow that occur as a result 
of alterations in brain activity, with increased blood flow in areas where neuronal activity 
increases [10, 11, 12].  PET is also able to measure changes in metabolism, while fMRI is 
able to measure changes in blood oxygen level dependent (BOLD) signal (a qualitative 
measure of neuronal activity).  In contrast to prior studies looking at changes in neuronal 
activity as recorded by electroencephalogram (EEG), PET and fMRI can objectively 
measure the subjective behavioral responses associated with anesthesia [1, 11].  
  
PET Imaging 
In a PET scan, cerebral metabolic rate of glucose consumption (CMRGlu) is 
measured with [18F]fluorodeoxyglucose (18FDG), and regional cerebral blood flow 
(rCBF) is measured with 15O-labeled water (H215O) [13].  PET studies allow for 
measurements of neuronal activity by measuring the changes in CBF or CMRGlu 
induced by neuronal activity.  In studying the effects of anesthetic agents, earlier studies 
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conducted using PET have shown a global decrease in metabolic activity reflecting the 
reduced neuronal activity in the brain under anesthesia [14, 15, 16].  However, 
subsequent PET studies have not only shown a generalized decreased in activity in the 
brain, but have also revealed regional variations in the amount of reduction in activity, 
especially with inhaled anesthetic agents [10, 17, 18].  The differences were most drastic 
when comparing volatile agents with propofol, which is consistent with the suggested 
notion that propofol has a different mechanism of action than inhaled agents, such as 
sevoflurane [19, 20].   
 Specifically, PET studies looking at the effects of isoflurane on human cerebral 
glucose metabolism have shown a nearly uniform reduction in whole-brain metabolic 
activity [15].  Similarly, studies looking at the effects of the inhaled anesthetic agent 
halothane on human cerebral glucose metabolism have shown whole-brain metabolic 
reduction with significantly less relative metabolism in the basal forebrain, thalamus, 
limbic system, cerebellum, and occiput while under high dose anesthesia [11, 16].   
Propofol too has been shown to induce a dose-dependent decrease in cerebral 
blood flow [21, 22, 23, 24].  When looking at cerebral metabolism during propofol 
anesthesia with PET, cortical metabolism decreased in all areas under anesthesia, but was 
not uniform [14, 23].  In contrast to inhaled anesthetics, cortical metabolism was more 
significantly depressed in comparison to subcortical metabolism, and the largest percent 
decrease was found to occur in the left anterior cingulate and the inferior colliculus [14, 
19, 20].  In addition, when looking at rCBF, large regional decreases have been shown to 
occur bilaterally in the medial thalamus, the cuneus and precuneus, and the posterior 
cingulate, orbitofrontal, and right angular gyri [23].  However, it is important to note that 
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these studies found non-uniform changes in rCBF, with some areas having a decrease in 
rCBF and others having an increase, though there could be overlapping regions obscuring 
other findings [10, 17, 18].   
 Although PET studies have revealed parts of the neuroanatomical regions 
important for anesthetic action, they have a low intrinsic spatial and temporal resolution 
[25].  They are based on a measurement at one point in time, and multiple measurements 
are difficult due to the half-life of the isotopes used.  In addition, PET studies require the 
injection of isotopes, and multiple blood samples must be drawn during the study.  In 
contrast, fMRI provides higher temporal and spatial resolution, does not necessitate the 
use of an exogenous tracer, and does not require a blood draw, allowing for multiple 
measurements in a single study [25].  
 
MRI—Basic Principles 
In a conventional MRI scan, a strong external magnetic field is used to align the 
H+ spins with the direction of the field.  A radiofrequency (RF) pulse is then used to 
produce a varying electromagnetic field.  The RF pulse has the correct resonance 
frequency to flip the spin of all the protons, and when it is turned off, the spins begin to 
return to their thermodynamic equilibrium [26].  The receiving coils then measure the 
radiofrequency signal generated by these protons returning to equilibrium.  This 
radiofrequency signal is structure specific, allowing for the structural image to be mapped 
based on the signal generated.  By applying different magnetic field gradients, images 
can be obtained in different orientations. 
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Functional MRI (fMRI) 
In contrast to conventional MRI, which produces static structural images, fMRI is 
used to detect changes in the brain caused by neuronal activity.  BOLD and rCBF are the 
two measures of neuronal activity measured in fMRI.   
 
Blood Oxygen Level Dependent (BOLD) Contrast 
BOLD is based on the concept that there are differences in magnetic properties 
between arterial and venous blood due to differences in oxygen concentration, forming 
the basis for blood oxygen level dependent (BOLD) intrinsic contrast.  Specifically, 
deoxyhemoglobin has paramagnetic properties and oxyhemoglobin does not, and BOLD 
is sensitive to local changes in deoxyhemoglobin concentration [26].  The BOLD signal 
is proportional to the ratio of oxyhemoglobin to deoxyhemoglobin.  With increased 
neuronal activity, there is an increase in oxygen consumption as well as cerebral blood 
flow.  However, the increase in blood flow is out of proportion to the increase in 
metabolism and oxygen consumption, resulting in a lower concentration of 
deoxyhemoglobin in areas of increased activity, which forms the basis of BOLD [27, 28].  
Thus, with increased neuronal activity and less deoxyhemoglobin as a result of a greater 
increase in regional cerebral blood flow, there would be less spin dephasing and an 
increase in MR signal [27].  It is important to note that BOLD is a qualitative measure of 
neuronal activity; hence, the relative change in BOLD is more important than the 
absolute BOLD value. 
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Pulsed Arterial Spin Labeling (PASL) Technique 
For measuring rCBF, perfusion imaging is done by differentiating the arterial 
water proton spins from the tissue water spins using a labeling technique, such as arterial 
spin labeling (ASL), and then observing the signal change following the free diffusion of 
the arterial water with tissue water [29, 30].  The common principles of perfusion 
imaging is that the concentration of a tracer must be known within the arterial blood 
supply and in the tissue, as well the partition coefficient of the tracer [31].  In ASL, this 
occurs through proximal labeling of arterial water spins using a selective preparation 
sequence, and acquiring two successive images after a small delay of time.  Subtraction 
of these images, one with and one without the labeling of the freely diffusible arterial 
water, allows us to calculate the perfusion to a certain region of the brain [32].  In 
contrast to BOLD intrinsic contrast, which is heavily weighted toward venous outflow, 
arterial spin labeling is a measurement at the capillary level, making it a relatively more 
accurate assessment of neuronal activity [33].  Moreover, the absolute rCBF is measured 
in pulsed arterial spin labeling (PASL). 
In the PASL technique, a short radiofrequency (RF) pulse is used to invert the 
longitudinal magnetization spin of the arterial blood upstream of the region of interest 
(ROI), as described in Figure 1.  Using spin echo imaging, the difference in signal 
between measurements with and without labeling allows for calculation of the amount of 
blood arriving to that particular volume of the brain.  Because the labeling is done closer 
to the acquisition plane, there is a much better signal-to-noise ratio with PASL [32].  
Prior to the advent of PASL, one major problem in perfusion imaging was the variable 
arterial transit time from the labeling to the region of interest, during which longitudinal 
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relaxation of the labeled spin led to a decrease in signal [30].  However, due to the 
drastically reduced transit time with PASL, it is possible to get a much more accurate 
quantification of cerebral blood flow to a particular region of interest [30].  Nonetheless, 
the rapid imaging required in PASL does reduce the spatial resolution to an extent. 
 
 
 
 
 
 
 
 
 
Figure 1.  Illustration of pulsed arterial spin labeling.  White circles with down arrows 
represent the magnetized spins (protons).  Gray circles with upward arrows represent 
those spins that have flipped back as they pass through the capillary bed.  The proportion 
is a direct measurement of perfusion.  Adapted from Golay X et al. 2004, ©Lippincott 
Williams & Wilkins [32]. 
 
Due to the property of neurovascular coupling in the brain, changes in blood flow 
accurately reflect changes in neuronal activity.  Neurovascular coupling was first 
described in 1890, and refers to a range of mechanisms that exist in the brain that work 
on arteriolar tone to adjust blood flow according to metabolic needs [34, 35, 36].  This 
Image removed in consideration of US 
Copyright Law 
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allows CBF to be an accurate representation of the change in cerebral metabolic rate of 
oxygen (CMRO2).  However, studies have shown that pathological conditions that disrupt 
capillary morphology, including amyloid, diabetes, or hypertensive microangiopathy, 
may result in inaccurate flow-metabolism coupling [35].  Hence, flow-metabolism 
coupling is best used as a measure of neuronal activity in healthy subjects. 
 
Anesthesia and fMRI 
Despite the great potential of fMRI to study the effects of anesthetic agents on the 
brain, only a small number of studies have been done.  Functional MRI studies done 
using subanesthetic concentrations of volatile agents have shown a decrease in activity in 
specific neural networks with decrease in activation induced response rather than a global 
decrease in neuronal activity [25, 33].  Specifically, Heinke et al. (2001) used 
subanesthetic doses of isoflurane in healthy volunteers to study task-induced brain 
activation.  Activation induced response allows one to study specific areas of the brain by 
using tasks known to activate that area and measure changes in activity at baseline and 
with an anesthetic to determine the change in activity caused by the anesthetic agent.  
Heinke et al. (2001) found that isoflurane caused a decrease in visual search task-induced 
brain activation in the right anteriosuperior insula and the banks of the left and right 
intraparietal sulcus, but no change in areas associated with primary information 
processing, including the lateral geniculate nucleus, primary visual cortex, and motor 
cortex [25].  Similarly, 0.25 MAC sevoflurane has been shown to decrease task-induced 
activation in the primary and secondary visual cortices, thalamus, hippocampus, and 
supplementary motor area without causing a significant global decrease in activity [33].  
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These fMRI studies have reported a relatively greater spatial resolution then previously 
seen with PET imaging [23, 27]. 
 Our prior studies have shown 0.5 MAC sevoflurane to decrease rCBF in various 
areas of the frontal, parietal, temporal, and occipital lobes, as well as in the anterior 
cingulate, cingulate gyrus, lentiform nucleus, thalamus, and cerebellum.  In addition, we 
found sevoflurane to cause an increase in rCBF in the superior temporal gyrus, middle 
temporal gyrus, lingual gyrus, parahippocampal gyrus, anterior cingulate, cingulate 
gyrus, claustrum, insula, and pons.  In the present study, we are investigating the 
influence of 0.5 MAC equivalent propofol anesthesia on rCBF in healthy volunteers in 
order to better understand the mechanism of action of propofol and compare it to the 
equivalent dose of sevoflurane. 
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STATEMENT OF PURPOSE 
The goal of this study is to help us better understand how two commonly used 
anesthetic agents (propofol and sevoflurane) affect the central nervous system and the 
similarities and differences in their effects.  This in turn will help in selecting the 
appropriate combination of anesthetic drugs in patients, with minimal side effects.  These 
experiments also give us information on how the central nervous system communicates 
form cortical to subcortical areas.  Moreover, given the recent concern regarding the 
neurotoxic effects of anesthetic agents, this study will allow us to better understand which 
areas of the brain are most affected by two commonly used anesthetic agents.  These 
areas can then further be studied in animal models to determine if general anesthetics do 
in fact have neurotoxic effects leading to neurodegeneration.  We hypothesize that 
“sevoflurane and propofol produce spatially non-uniform changes in rCBF, with some 
areas manifesting a decrease in rCBF and others an increase.”  This study will also clarify 
the similarities and differences between the two commonly used anesthetic agents at 
clinically relevant concentrations.    
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METHODS 
The study protocol was approved by the Yale University Human Investigation 
Committee.   
 
Subjects 
Thirty consenting American Society of Anesthesiologists (ASA) patient classification 
status I healthy volunteers aged 19 to 30 years old were studied.  All subjects were 
required to go through a clinical screening, including a history and physical examination, 
within 7 days prior to the study.  Screening involved a history of any medical problems, 
surgical history, medication use and any history of adverse reactions to anesthesia.  The 
physical exam involved checking vitals signs (heart rate, blood pressure, respiratory rate), 
auscultation to rule out cardiac and respiratory problems, and an airway exam to ensure 
that the subject was not prone to airway obstruction during anesthesia.  Only ASA class I 
subjects with no systemic problems and body weight within 20% of the ideal weight for 
their height were selected for the study.   
Exclusion criteria:  
1) Subjects with a history of milk or egg allergy were not included.  
2) Subjects on centrally acting medications such as antidepressants were not included.  
3) Those subjects with contraindications to MRI (e.g. subjects with metal implants) were 
also excluded.   
The experimental protocol of imaging and anesthesia were described to all 
subjects before the study.  All subjects completed a MR safety questionnaire.  Subjects 
were given a consent form to take home, read, and have ample time to seek any 
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clarifications.  On the day of the study, they brought the signed consent form and had any 
remaining questions answered.  On arrival at the Magnetic Resonance Research Center, 
the subjects were screened for the presence of any ferromagnetic substance and other 
contraindications for MRI.  Subjects were checked with a metal detector prior to entering 
the MR scan room.  Female subjects were required to undergo a urine pregnancy test, and 
only those subjects having a negative pregnancy test were included in this study.  
Although no harmful biological effects of MRI on pregnancy have been identified to 
date, it is the policy of the Yale HIC to exclude pregnant women in all MRI research 
studies.  All subjects were weighed prior to the study and an intravenous (IV) cannula 
was placed under sterile conditions for Propofol infusion.  A second IV cannula was 
placed under sterile conditions for drawing blood samples for propofol assay, which is 
described below.  Subjects were monitored as per ASA basic standards of monitoring.  
Sedation level was evaluated and graded according to the observer’s assessment of 
alertness/sedation (OAA/S) rating scale (Figure 2). 
 
Figure 2.  Observer’s assessment of alertness/sedation (OAA/S).  Adapted from 
Clouzeau et al. 2010 [37, 38]. 
Image removed in consideration of US Copyright Law 
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Anesthesia 
All subjects were told to fast for eight hours prior to the study.  Propofol anesthesia was 
administered through a Target Controlled Infusion (TCI) device (STANPUMP pump 
connected to a Harvard 22 syringe pump).  STANPUMP is available from Steven L. 
Shafer, M.D., Anesthesiology Service (112A), PAVAMC, 3801 Miranda Ave., Palo Alto, 
CA 94304.  STANPUMP is a pharmacokinetic infusion program (also referred to as the 
target controlled infusion—TCI pump).  This software in a laptop drove the Harvard 22 
syringe pump at the required rate (depending on the subject’s pharmacokinetics) in order 
to achieve the selected target propofol level.  The selected TCI propofol plasma level was 
2 µg/mL (equivalent to 0.5 MAC level), with the rate of infusion determined by the 
subject’s weight, height, and sex.  For anesthesia, the required propofol plasma level is 3-
4 µg/mL.  Subjects inhaled oxygen through a nasal cannula at 4 liters per minute 
throughout the study.  An experienced anesthesiologist was present throughout the entire 
assessment, and full anesthesia and resuscitation equipment was always available. 
Propofol level was confirmed by drawing a 3 cc blood sample at the beginning and end of 
the propofol infusion period.  Blood samples were stored at -80°C and sent to a UCSF 
laboratory for propofol assay.  
 
Imaging 
Magnetic resonance imaging data were acquired on a 3 Tesla whole-body scanner Trio 
(Siemens Medical Systems, Erlangen, Germany) with a 12-channel phased-array head 
coil.  Pulsed arterial spin labeling imaging was used to measure perfusion-induced 
changes in image signal intensity during the resting state.  The QUIPSS PASL sequence 
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was used for measuring the resting-state CBF in the awake and anesthesia conditions 
[39].  Interleaved labeling and control images were acquired using a gradient echo-planar 
imaging (EPI) sequence.  A slab-selective (100 mm) hyper-secant inversion 
radiofrequency (RF) pulse was used for ASL.  The RF pulse was applied to a slab 25 mm 
inferior to the imaging slab and the same RF pulse was applied to a slab 25 mm superior 
to the imaging slab to control the off-resonance effects.  A 20-slice ASL acquisition was 
implemented and all slices were AC-PC angled and positioned to fully cover the brain 
cortex.  The ASL acquisition parameters were: field of view FOV = 256×256 mm2; 
matrix = 64×64; bandwidth = 2004 Hz/pixel; slice thickness = 5 mm, and inter-slice gap 
= 2.5 mm.  The repetition time was TR = 3000 ms; the echo time was TE = 26 ms. 
Acquisition of each slice took approximately 60 ms, therefore the post-labeling inversion 
time for each slice i, i = 1, 2, …, TI(i) = 1400+60× (i-1) ms, which was used in CBF 
quantification, resulting a data acquisition window of 1.4 to 2.6 seconds after labeling.  
Proton density weighted images were collected using the same perfusion sequence, 
except for the following changes: TR was set to 10 seconds; the delay time TD was set to 
0 ms; and the inversion time TI was set to maximum.  Two additional acquisitions were 
acquired to aid in multi-subject registration.  First, a high-resolution whole brain 3D 
structure image was acquired for each subject using MPRAGE (Magnetization Prepared 
Rapid Acquisition with Gradient-Echo imaging), with the following settings: 160 sagittal 
slices with FOV = 256× 256 mm2; voxel size = 1× 1 × 1 mm3; TR = 1500 ms; TI = 800 
ms; TE = 2.83 ms; flip angle 15 degrees; and one average.  Next, two sets of multi-slice 
2D T1-weighted images, each for one part of the brain, were acquired during each MR 
session using the same slice positions as the perfusion-weighted images with the 
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following settings: FOV = 256× 256 mm2; in-plane resolution 1× 1 mm2; TR = 300 ms; 
TE = 3.69 ms; flip angle 60 degrees; and two averages. 
The subjects stayed still with eyes closed in the scanner during the MRI 
experiment.  Two PASL runs, each of 200 volumes, were acquired for the awake 
condition and for the anesthesia conditions, respectively.  For the anesthesia condition, 
the MRI scans only started ~10 minutes after the anesthetic was delivered to the subjects. 
These perfusion-weighted data were later used to calculate absolute CBF on a per-voxel 
basis. 
 
Quantification of Regional Cerebral Blood Flow 
Perfusion-weighted and the proton-density weighted images were motion-corrected using 
the Statistical Parametric Mapping package (SPM99), via a 6-parameter rigid-body 
transformation.  Time series of the perfusion-weighted images were obtained by pair-
wise “surround” subtraction between interleaved label and control pairs for either the 
resting state, resulting in a temporal resolution of 2TR [40, 41, 42].  Perfusion-induced 
difference maps (ΔM) were calculated by averaging all the difference images in the time 
series for the whole resting state.  The mean image of the motion-corrected proton 
density images (M0) was estimated by averaging multiple acquisitions.  The absolute 
CBF (f ) (ml/100g/minute) was calculated: 
 
ΔM (t) = Mctrl (t)−Mlabel (t) = 2cf (t −τ a )M0
*
λ
e−t /Τ1a    (1) 
 
in which,  	  
λ is the tissue-blood partition coefficient for water; 	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c =απ
1− e−(t−τa )(1/T1app −1/T1a )
(t −τ a )(1 /T1app −1 /T1a )
     (2)	  	  
is the correction factor, which accounts for exchange of labeled magnetization from 
intravascular to extravascular space and clearance of the labeled blood water out of the 
capillary bed; 	  
aτ  is the arterial transit time, which is the time for the labeled blood water to arrive at the 
capillary bed after labeling, and	  	  
M0* = M0e−TE /T2
* .       (3) 
 
appT1  is the apparent longitudinal relaxation time.  In Equation (2), when 
)/1/1)(( 11 aappa TTt −−τ is small, πα≈c .  Other parameters used in CBF quantification: 
T1a = 1490ms , gml /9.0=λ , 95.0=πα , mst a 700=−τ , and TI = 1400 ms for the first 
slice.  After *0M , appT1 , and MΔ have been measured on a per-voxel basis, CBF (f) can 
then be estimated using Equation (1). 
 
Inter-Subject Data Integration 
A standard whole brain template (MNI-1mm) was used for subject spatial normalization 
of the group data.  Registration of multiple subject data and group analyses were carried 
out using the BioimageSuite software package bioimagesuite.org [43].  Two 
transformations were performed to allow multiple subject integration: first, a linear 
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transformation was estimated by co-registering the subject’s multi-slice 2D T1-weighted 
images to the high-resolution 3D anatomical image of the same subject, and this was then 
used to transform the individual CBF maps of both the resting state and task-induced data 
to the high-resolution 3D anatomical space of that subject; second, a non-linear 
transformation was used to co-register the high-resolution 3D anatomical image of each 
subject to the common brain MNI-1mm template, which enabled warping of all the 
transformed maps of a subject to the common brain space.  Tri-linear interpolation was 
employed for image re-gridding in the common 3D space.  All group analysis was 
performed in the common space and regional CBF significantly altered by both 
anesthetics was overlaid on the high resolution anatomical image and presented in this 
composite space.  The difference between the baseline CBF in the awake state and with 
propofol (δCBF) was calculated to determine the effect of propofol on baseline activity.  
Areas where cerebral blood flow was significantly altered from baseline (p < 0.05) were 
defined.  The Talairach atlas was then used to identify these regions, and they are listed in 
Table 1. 
 
Discharge Criteria 
After the anesthesia cycle imaging, the propofol infusion was discontinued and subjects 
were brought out of the scanner.  They were transferred to a stretcher and observed for 45 
minutes to ensure they met the criteria for discharge.  Criteria for discharge were the 
same as those used in the Yale New Haven Hospital ambulatory surgery unit, including 
stable vital signs, awake, alert, talking, and ambulating without support (ASA standard 
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practice).  The IV cannulas were then removed from their arms and they were sent home 
with a responsible adult.  Subjects were advised to not drive for the following 24 hours.   
 
Table 1. Various anatomical regions where rCBF was significantly altered from baseline 
with 2 µg/mL propofol anesthesia. 
Anatomical	  Regions	   Talairach	  
Coordinates	  
Volume	  
(mm3)	  
Lobe	   Region	   X	   Y	   Z	   	  
	  Right	   Parietal	  Lobe	   Postcentral	  Gyrus	   44	   -­‐36	   60	   909	  
	  Right	   Frontal	  Lobe	   Precentral	  Gyrus	   58	   -­‐6	   44	   348	  
	  Right	   Parietal	  Lobe	   Postcentral	  Gyrus	   18	   -­‐34	   60	   341	  
	  Right	   Frontal	  Lobe	   Precentral	  Gyrus	   58	   -­‐3	   45	   3182	  
	  Right	   Parietal	  Lobe	   Inferior	  Parietal	  Lobule	   45	   -­‐41	   55	   17732	  
	  Left	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   -­‐27	   25	   47	   5379	  
	  Left	   Frontal	  Lobe	   Superior	  Frontal	  Gyrus	   -­‐36	   35	   32	   12137	  
	  Right	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   38	   54	   -­‐7	   18523	  
	  Right	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   36	   54	   -­‐9	   12103	  
	  Left	   Frontal	  Lobe	   Inferior	  Frontal	  Gyrus	   -­‐26	   15	   -­‐14	   655	  
	  Right	   Frontal	  Lobe	   Subcallosal	  Gyrus	   24	   8	   -­‐13	   55	  
	  Left	   Occipital	  Lobe	   Cuneus	   -­‐2	   -­‐92	   0	   5989	  
	  Left	   Occipital	  Lobe	   Cuneus	   -­‐2	   -­‐92	   2	   25794	  
	  Left	   Occipital	  Lobe	   Middle	  Occipital	  Gyrus	   -­‐27	   -­‐84	   13	   21292	  
	  Left	   Temporal	  
Lobe	  
Fusiform	  Gyrus	   -­‐53	   -­‐34	   -­‐21	   7224	  
	  Right	   Temporal	  
Lobe	  
Middle	  Temporal	  Gyrus	   62	   -­‐39	   -­‐14	   5483	  
	  Left	   Temporal	  
Lobe	  
Superior	  Temporal	  
Gyrus	  
-­‐62	   -­‐18	   3	   318	  
	  Right	   Limbic	  Lobe	   Posterior	  Cingulate	   4	   -­‐44	   24	   10310	  
	  Right	   Limbic	  Lobe	   Posterior	  Cingulate	   3	   -­‐41	   22	   381	  
	  Right	   Limbic	  Lobe	   Posterior	  Cingulate	   7	   -­‐51	   25	   10290	  
	  Left	   Frontal	  Lobe	   Medial	  Frontal	  Gyrus	   -­‐3	   41	   -­‐9	   748	  
	  Right	   Temporal	  
Lobe	  
Middle	  Temporal	  Gyrus	   62	   -­‐40	   -­‐13	   9710	  
	  Right	   Temporal	  
Lobe	  
Superior	  Temporal	  
Gyrus	  
34	   13	   -­‐32	   3007	  
	  Right	   Parietal	  Lobe	   Precuneus	   41	   -­‐72	   42	   14419	  
	  Right	   Parietal	  Lobe	   Precuneus	   41	   -­‐72	   41	   1081	  
	  Left	   Sub-­‐lobar	   Extra-­‐Nuclear	   -­‐35	   -­‐24	   4	   129	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  Left	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   -­‐48	   24	   23	   1101	  
	  Left	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   -­‐51	   24	   22	   1822	  
	  Right	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   38	   39	   23	   6240	  
	  Right	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   47	   46	   -­‐8	   6577	  
	  Right	   Sub-­‐lobar	   Thalamus	   14	   -­‐23	   16	   2233	  
	  Right	   Sub-­‐lobar	   Lentiform	  Nucleus	   31	   -­‐19	   5	   98	  
Right	   Sub-­‐lobar	   Medial	  Dorsal	  Nucleus	   7	   -­‐18	   10	   13119	  
Right	   Limbic	  Lobe	   Cingulate	  Gyrus	   1	   -­‐8	   44	   119	  
	  Left	   Limbic	  Lobe	   Cingulate	  Gyrus	   -­‐4	   10	   33	   64	  
	  Inter	   Hemispheric	   Corpus	  Callosum	   1	   18	   16	   1200	  
Right	   Limbic	  Lobe	   Parahippocampal	  
Gyrus	  
19	   -­‐23	   -­‐15	   4257	  
	  Left	   Limbic	  Lobe	   Parahippocampal	  
Gyrus	  
-­‐15	   -­‐15	   -­‐15	   693	  
	  Right	  
.	  
Limbic	  Lobe	   Posterior	  Cingulate	   4	   -­‐45	   20	   32	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RESULTS 
Thirty healthy ASA I volunteers were studied.  There were 17 men and 13 women and 
their average age was 23 years.  Their mean height, body weight, and body mass index 
were 170.2 cm, 68.8 kg and 23.73 kg/m2, respectively.  Their vital signs, including their 
heart rate, mean arterial pressure and end tidal CO2 were all within physiological range 
during the course of the study, as seen in Table 2.  All subjects completed the study 
successfully without any complications and were discharged within 30 to 45 minutes 
after completion of the study. 
 
Table 2.  Illustrates the mean ± standard deviation oxygen saturation (SpO2), end tidal 
carbon dioxide (ET-CO2), respiratory rate (RR), systolic blood pressure (SBP), diastolic 
blood pressure (DBP), mean arterial pressure (MAP), and heart rate (HR) in all subjects 
at baseline and during 2 µg/mL propofol anesthesia. 
 
 Baseline 2 µg/mL Propofol 
SpO2 (%) 99 ± 1 98 ± 1 
ET-CO2 (mmHg) 34 ± 5 34 ± 6 
RR (bpm) 14 ± 2 15 ± 3 
SBP (mmHg) 110 ± 10 102 ± 9 
DBP (mmHg) 64 ± 8 55 ± 9 
MAP (mmHg) 79 ± 8 71 ± 8 
HR (bpm) 59 ± 9 62 ± 10 
 
 
Neurologic Status 
With 2 µg/mL propofol, all subjects were asleep and not responding to verbal command.  
The lowest OAAS score, as described in Figure 2, during propofol anesthesia was 3/5 
[37].  No subjects had any recollection of the anesthesia state at the end of the study. 
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Effect of 2 µg/mL Propofol on baseline CBF 
The difference between baseline CBF in the awake state and with propofol in the various 
anatomical regions (δCBF) is shown in Tables 3 and 4.  The δCBF was non-uniform in 
various anatomical regions, with some areas experiencing a decrease in rCBF and others 
experiencing an increase.  Specifically, the posterior cingulate, thalamus, lentiform 
nucleus, medial dorsal nucleus, and several areas within the frontal, parietal, temporal, 
and occipital lobes had a significant decrease in rCBF under propofol anesthesia.  In 
contrast, the cingulate gyrus, parahippocampal gyrus, posterior cingulate, and the corpus 
callosum had an increase in rCBF under propofol anesthesia.  Figure 3 shows the 
averaged rCBF at baseline in all subjects, while Figure 4 shows the averaged rCBF with 2 
µg/mL propofol anesthesia.  Figure 5 shows the image of propofol-induced changes in 
rCBF, illustrating those areas with a significant change in CBF (p<0.05).  Figure 6 
highlights these changes within the thalamus.  Thalamic activity correlates with loss of 
consciousness under anesthesia. 
 
Table 3.  δCBF in the various anatomical regions where rCBF significantly decreased 
with 2 µg/mL propofol anesthesia (p < 0.05). 
Anatomical	  Regions	   Talairach 
Coordinates 
Vol. 
(mm3) 
δCBF	  
(ml	  	  
/100g	  	  
/min)	  
Lobe	   Region	   	   	   	  Right	   Frontal	  Lobe	   Precentral	  Gyrus	   (58,	  -­‐6,	  44)	   909	   -­‐8.7	  Right	   Frontal	  Lobe	   Precentral	  Gyrus	   (58,	  -­‐3,	  45)	   3182	   -­‐9.2	  Right	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   (38,	  54,	  -­‐7)	   18523	   -­‐14.9	  Right	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   (36,	  54,	  -­‐9)	   12103	   -­‐14.9	  Right	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   (38,	  39,	  23)	   6240	   -­‐12.0	  Right	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   (47,	  46,	  -­‐8)	   6577	   -­‐11.7	  Right	   Frontal	  Lobe	   Subcallosal	  Gyrus	   (24,	  8,	  -­‐13)	   55	   -­‐8.6	  
22 	  Left	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   (-­‐27,	  25,	  47)	   5379	   -­‐10.0	  Left	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   (-­‐48,	  24,	  23)	   1101	   -­‐9.2	  Left	   Frontal	  Lobe	   Middle	  Frontal	  Gyrus	   (-­‐51,	  24,	  22)	   1822	   -­‐8.3	  Left	   Frontal	  Lobe	   Medial	  Frontal	  Gyrus	   (-­‐3,	  41,	  -­‐9)	   748	   -­‐3.0	  Left	   Frontal	  Lobe	   Superior	  Frontal	  Gyrus	   (-­‐36,	  35,	  32)	   12137	   -­‐10.3	  Left	   Frontal	  Lobe	   Inferior	  Frontal	  Gyrus	   (-­‐26,	  15,	  -­‐14)	   655	   -­‐6.9	  Right	   Parietal	  Lobe	   Postcentral	  Gyrus	   (44,	  -­‐36,	  60)	   909	   -­‐2.9	  Right	   Parietal	  Lobe	   Postcentral	  Gyrus	   (18,	  -­‐34,	  60)	   341	   -­‐8.7	  Right	   Parietal	  Lobe	   Inferior	  Parietal	  Lobule	   (45,	  -­‐41,	  55)	   17732	   -­‐10.5	  Right	   Parietal	  Lobe	   Precuneus	   (41,	  -­‐72,	  42)	   14419	   -­‐9.5	  Right	   Parietal	  Lobe	   Precuneus	   (41,	  -­‐72,	  41)	   1081	   -­‐9.6	  Right	   Temporal	  Lobe	   Superior	  Temp.	  Gyrus	   (34,	  13,	  -­‐32)	   3007	   -­‐11.3	  Right	   Temporal	  Lobe	   Middle	  Temporal	  Gyrus	   (62,	  -­‐40,	  -­‐13)	   9710	   -­‐6.1	  Right	   Temporal	  Lobe	   Middle	  Temporal	  Gyrus	   (62,	  -­‐39,	  -­‐14)	   5483	   -­‐11.1	  Left	   Temporal	  Lobe	   Superior	  Temp.	  Gyrus	   (-­‐62,	  -­‐18,	  3)	   318	   -­‐5.4	  Left	   Temporal	  Lobe	   Fusiform	  Gyrus	   (-­‐53,	  -­‐34,	  -­‐21)	   7224	   -­‐10.6	  Left	   Occipital	  Lobe	   Cuneus	   (-­‐2,	  -­‐92,	  0)	   5989	   -­‐13.5	  Left	   Occipital	  Lobe	   Cuneus	   (-­‐2,	  -­‐92,	  2)	   25794	   -­‐13.7	  Left	   Occipital	  Lobe	   Middle	  Occipital	  Gyrus	   (-­‐27,	  -­‐84,	  13)	   21292	   -­‐9.9	  Right	   Limbic	  Lobe	   Posterior	  Cingulate	   (4,	  -­‐44,	  24)	   10310	   -­‐10.5	  Right	   Limbic	  Lobe	   Posterior	  Cingulate	   (3,	  -­‐41,	  22)	   381	   -­‐11.2	  Right	   Limbic	  Lobe	   Posterior	  Cingulate	   (7,	  -­‐51,	  25)	   10290	   -­‐11.6	  Right	   Sub-­‐lobar	   Thalamus	   (14,	  -­‐23,	  16)	   2233	   -­‐4.4	  Right	   Sub-­‐lobar	   Lentiform	  Nucelus	   (31,	  -­‐19,	  5)	   98	   -­‐4.3	  Right	   Sub-­‐lobar	   Medial	  Dorsal	  Nucleus	   (7,	  -­‐18,	  10)	   13119	   -­‐12.2	  Left	   Sub-­‐lobar	   Extra-­‐Nuclear	   (-­‐35,	  -­‐24,	  4)	   129	   -­‐7.2	  	  	  	  
Table 4.  δCBF in the various anatomical regions where rCBF significantly increased 
with 2 µg/mL propofol anesthesia (p < 0.05). 
Anatomical	  Regions	   Talairach 
Coordinates 
Vol. 
(mm3) 
δCBF	  
(ml	  	  
/100g	  	  
/min)	  
Lobe	   Region	   	   	   	  Right	   Limbic	  Lobe	   Cingulate	  Gyrus	   (1,	  -­‐8,	  44)	   119	   4.5	  Right	   Limbic	  Lobe	   Parahippocampal	  Gyrus	   (19,	  -­‐23,	  -­‐15)	   4257	   14.8	  Right	   Limbic	  Lobe	   Posterior	  Cingulate	   (4,	  -­‐45,	  20)	   32	   5.6	  Left	   Limbic	  Lobe	   Cingulate	  Gyrus	   (-­‐4,	  10,	  33)	   64	   3.2	  Left	   Limbic	  Lobe	   Parahippocampal	  Gyrus	   (-­‐15,	  -­‐15,	  -­‐15)	   693	   2.6	  Inter	   Hemispheric	   Corpus	  Callosum	   (1,	  18,	  16)	   1200	   5.9	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Figure 3.  Illustrates the averaged baseline regional cerebral blood flow before anesthesia 
in all subjects. 
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Figure 4.  Illustrates the averaged regional cerebral blood flow (rCBF) with propofol 2 
µg/ml in all subjects.   
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Figure 5.  Illustrates the averaged change in regional cerebral blood flow (δCBF) with 
propofol 2 µg/ml in various voxels of the brain.  Red/orange areas imply an increase in 
rCBF and purple/blue areas reflect a decrease in rCBF (p < 0.05). 
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Figure 6.  Illustrates the change in regional cerebral blood flow (δCBF) with propofol 2 
µg/ml within the thalamus.  Red/orange areas imply an increase in rCBF and purple/blue 
areas reflect a decrease in rCBF (p < 0.05). 
 
 
Comparison of changes in rCBF in propofol vs. sevoflurane 0.5 MAC anesthesia 
The measured δCBF with 0.5 MAC equivalent propofol anesthesia was then compared 
qualitatively to that observed with 0.5 MAC sevoflurane.  Tables 5 and 6 illustrate δCBF 
in the various anatomical regions where rCBF decreased and increased, respectively, with 
0.5 MAC sevoflurane. Areas with a significant decrease in rCBF include the anterior 
cingulate, cingulate gyrus, lentiform nucleus, thalamus, and cerebellum, as well as areas 
within the frontal, parietal, temporal, and occipital lobes.  In contrast, areas with a 
significant increase in rCBF with 0.5 MAC sevoflurane include the superior temporal 
gyrus, anterior cingulate, cingulate gyrus, claustrum, insula, and pons. 
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Table 5.  δCBF in the various anatomical regions where rCBF significantly decreased 
under 0.5 MAC sevoflurane anesthesia (p < 0.05).  Data provided courtesy of 
Ramachandran Ramani, Yale School of Medicine, and adapted for comparison. 
Anatomical Regions Talairach 
Coordinates 
δCBF 
(ml/100g/min) 
Lobe Region   
Right Frontal Lobe Middle Frontal Gyrus (30, 34, -8) -9 
Right Frontal Lobe Middle Frontal Gyrus (34, 24, 40) -9 
Right Frontal Lobe Medial Frontal Gyrus (13, 45, 4) -11 
Right Frontal Lobe Subcallosal Gyrus (12, 11, -11) -12 
Left Frontal Lobe Middle Frontal Gyrus (-28, 35, -13) -20 
Left Frontal Lobe Middle Frontal Gyrus (-42, 29, 39) -11 
Left Frontal Lobe Subgyral (-11, 34, -14) -18 
Right Parietal Lobe Inferior Parietal Lobule (60, -27, 29) -10 
Right Parietal Lobe Inferior Parietal Lobule (53, -40, 40) -9 
Left Parietal Lobe Inferior Parietal Lobule (-61, -30, 28) -13 
Left Parietal Lobe Inferior Parietal Lobule (-55, -37, 40) -9 
Right Temporal Lobe Superior Temporal Gyrus (33, 10, -38) -13 
Left Temporal Lobe Superior Temporal Gyrus (-31, 5, -31) -20 
Left Occipital Lobe Cuneus (-2, -97, 3) -17 
Right Limbic Lobe Anterior Cingulate (11, 44, 3) -12 
Left Limbic Lobe Cingulate Gyrus (-1, -26, 28) -20 
Left Sub-lobar Lentiform Nucleus (-14, 11, -10) -21 
Right Thalamus Medial Dorsal Nucleus (8, -21, 10) -9 
Right Thalamus Ventral Anterior Nucleus (7, -13, 16) -10 
Left Thalamus Medial Dorsal Nucleus (-8, -21, 8) -10 
Left Thalamus Ventral Anterior Nucleus (-9, -13, 15) -9 
Right Cerebellum Pyramis (39, -77, -33) -20 
Right Cerebellum Cerebellar Tonsil (44, -51, -33) -33 
Left Cerebellum Pyramis (-47, -70, -33) -14 
Left Cerebellum Cerebellar Tonsil (-42, -49, -34) -16 
Left Cerebellum Culmen (-4, -49, -9) -11 
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Table 6.  δCBF in the various anatomical regions where rCBF significantly increased 
under 0.5 MAC sevoflurane anesthesia (p < 0.05).  Data provided courtesy of 
Ramachandran Ramani, Yale School of Medicine, and adapted for comparison. 
Anatomical Regions Talairach 
Coordinates 
δCBF 
(ml/100g/min) 
Lobe Region   
Right Temporal Lobe Superior Temporal Gyrus (41, 2, -19) 9 
Right Temporal Lobe Middle Temporal Gyrus (62, -39, -7) 13 
Left Temporal Lobe Superior Temporal Gyrus (-50, 1, -7) 12 
Left Temporal Lobe Middle Temporal Gyrus (-41, 2, -20) 10 
Left Temporal Lobe Middle Temporal Gyrus (-42, 0, -25) 12 
Right Occipital Lobe Lingual Gyrus (22, -59, 3) 11 
Right Limbic Lobe Parahippocampal Gyrus (21, -27, -7) 11 
Right Limbic Lobe Parahippocampal Gyrus (21, -44, -6) 11 
Right Limbic Lobe Parahippocampal Gyrus (14, -44, 0) 10 
Right Limbic Lobe Anterior Cingulate (0, 30, 4) 9 
Left Limbic Lobe Parahippocampal Gyrus (-31, -21, -23) 11 
Left Limbic Lobe Parahippocampal Gyrus (-24, -26, -9) 11 
Left Limbic Lobe Parahippocampal Gyrus (-27, -43, -7) 9 
Left Limbic Lobe Parahippocampal Gyrus (-19, -44, 0) 11 
Left Limbic Lobe Cingulate Gyrus (-1, 15, 29) 8 
Right Sub-lobar Claustrum (37, 1, -8) 12 
Right Sub-lobar Insula (39, 5, -1) 11 
Left Sub-lobar Insula (-39, 6, 0) 9 
Right Brainstem Pons (9, -16, -19) 18 
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DISCUSSION 
The present study address three main questions:  
1) How does 0.5 MAC equivalent propofol anesthesia affect regional cerebral blood flow 
and thus regional neuronal activity?  
2) How do these changes compare to that observed with 0.5 MAC sevoflurane anesthesia 
in an earlier study? 
3) What is the neurophysiological significance of the observed changes in regional 
cerebral blood flow?  
Our results clearly illustrate that propofol causes a non-uniformity in rCBF.  
Regions manifesting a rise in rCBF include the cingulate gyrus, parahippocampal gyrus, 
posterior cingulate, and the corpus callosum.  Regions manifesting a decrease in rCBF 
include several areas within the frontal, parietal, temporal, and occipital lobes, as well as 
the posterior cingulate, thalamus, lentiform nucleus, and medial dorsal nucleus. 
 
Effects of propofol on the frontal lobe 
 Within the frontal lobe, propofol caused the most drastic decrease in CBF in 
bilateral middle frontal gyri in addition to the left medial frontal gyrus, left superior 
frontal gyrus, left inferior frontal gyrus, right precentral gyrus, and right subcallosal gyrus 
(Figure 7).  No regions within the frontal lobe had a significant increase in regional 
cerebral blood flow.  The frontal lobe is implicated in higher order processing functions 
of the brain, including executive functions and emotional memories linked with the 
limbic system, as well as in the control of autonomic responses [44, 45].  It receives input 
from the dorsomedial thalamic nucleus [46].   
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Figure 7.  Coronal section through the anterior horn of the lateral ventricles.  Illustrates 
the superior, middle, and inferior frontal gyri [47]. 
 
Studies looking at the action of middle frontal gyrus have found it to play a 
critical role in both the storage and processing components of working memory in the 
brain [46, 48].  It is part of the prefrontal cortex (PFC) and constitutes one third of the 
frontal lobe.  Thus, it can be inferred that propofol impairs working memory by 
decreasing its capacity.  The dorsolateral prefrontal cortex (DLPFC) forms the middle 
third of the middle frontal gyrus and is deactivated in REM sleep.  The superior frontal 
gyrus is involved in self-awareness, working with the sensory system [49].  In contrast, 
the inferior frontal gyrus has different roles in each hemisphere.  The right inferior frontal 
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gyrus plays a role in risk aversion while the left inferior frontal gyrus, also known as 
Broca’s area, plays a critical role in language production and verb comprehension [50, 
51].  This is consistent with previous findings showing the impaired recognition memory 
and verbal memory caused by propofol [52, 53].  It is important to note that significant 
decreases in cerebral blood flow with 0.5 MAC propofol anesthesia was only noted in the 
left inferior frontal gyrus and left superior frontal gyrus, indicating that these regions are 
more susceptible to the effects of propofol.  It has been implicated the propofol may 
specifically and preferentially affect higher processing areas of the brain, such as the 
frontal and temporal lobe, and our results reaffirm this theory [3].   
 
Effects of propofol on the parieto-occipito cortex 
The parieto-occipito cortex was another cortical region particularly affected by 
propofol.  Specifically, the right precuneus, right inferior parietal lobule, right postcentral 
gyrus, left cuneus and left middle occipital gyrus had significant decreases in rCBF.  The 
inferior parietal lobule is located below the horizontal portion of the intraparietal sulcus 
and behind the lower portion of the posterior central sulcus.  It is concerned with the 
perception of facial emotions and in sensory information interpretation [54].  It is also 
connected with language, mathematical operations, and body image.   
The cuneus and precuneus are involved in basic visual processing, episodic 
memory, and aspects of consciousness [21].  The cuneus is a wedge shaped portion of the 
occipital lobe seen predominantly on the medial side of the sagittal section of the brain.  
The left cuneus receives information from the inferior part of the right visual field and 
vice versa.  Evidence suggests that the precuneus plays a pivotal role in self-awareness 
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and in producing a conscious self-percept [55].  PET studies have shown that alterations 
in activity of the middle occipital lobe, cuneus, and precuneus modulate the level of 
consciousness, with propofol leading to a deactivation in these areas [23, 56, 57].  
Similarly, in our study, propofol led to a decrease in rCBF in these areas, suggesting that 
deactivation in these regions of the parieto-occipito cortex is important in achieving the 
pharmacological effects of propofol. 
 
Effects of propofol on the temporal lobe 
In the temporal lobe, bilateral superior temporal gyri as well as areas in the right 
middle temporal gyrus showed a significant decrease in rCBF from baseline with 
propofol.  The superior temporal gyrus is involved in the sensation of sound as well as in 
the processing of speech, as it contains the primary auditory cortex as well as Wernicke’s 
area [58].  In addition, this area has been implicated in the perception of emotion in facial 
expressions, as has the middle temporal gyrus [54].  Changes in regional cerebral blood 
flow to the temporal lobe perhaps reflect the breakdown of the language processing 
networks under propofol-induced anesthesia [59].  Functional imaging techniques have 
previously shown propofol to disrupt connections from the primary auditory cortex to the 
frontal regions and the thalamus [60]. 
 
Effects of propofol on the limbic lobe 
The limbic lobe is a C-shaped structure of the medial hemispheric surface, 
consisting of parts of the frontal, parietal, and temporal lobes.  It encircles the corpus 
callosum and the lateral aspect of the midbrain, and includes the cingulate gyrus, 
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parahippocampal gyrus, hippocampal formation, paraterminal gyrus and subcallosal area 
(Figure 8).  The limbic lobe plays a central role in memory, emotional processing, and in 
affective behaviors with strong emotional content [61].   
 
 
 
 
 
 
 
 
 
 
Figure 8.  Sagittal illustration of the brain highlighting key areas of the limbic lobe, 
including the subcallosal area, cingulate gyrus, hippocampal formation, and 
parahippocampal gyrus.  Adapted from Hesslink JR (2011) [62]. 
 
In the limbic lobe, both significant decreases and increases in rCBF were 
observed.  A decrease in rCBF was seen in the right posterior cingulate, while increases 
in rCBF occurred in bilateral parahippocampal gyri, bilateral cingulate gyri, and the right 
posterior cingulate. The posterior cingulate has been found to be functionally 
heterogeneous, and is implicated to play a role in pain processing and episodic memory 
retrieval, as well as serve as one of the neural substrates for human awareness [63].  It 
receives information from the thalamus and neocortex, and relays it to the entorhinal 
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cortex located in the medial temporal lobe.  Together with the precuneus, the posterior 
cingulate cortex plays a pivotal role in conscious information processing.  These regions 
have the highest level of metabolism in the human brain and form part of the neural 
network correlates of consciousness (NNCC) [64].  PET studies looking at rCBF with 
propofol have also shown a decrease in activity in the precuneus and posterior cingulate 
cortex with deepening of propofol-induced sedation, followed by a complete restoration 
of activity in these areas upon the return of consciousness [23, 65].  In our study, it was 
the only area within the limbic lobe that showed a decrease in rCBF, though there was a 
region in the right posterior cingulate and left cingulate gyrus that had an increase in 
rCBF.  There was also an increase in rCBF in the parahippocampal gyrus, which plays an 
important role in memory encoding and retrieval.  Increased activity in this area with 
anesthesia is intriguing and must be further investigated.  Studies have shown that 
stimulation in the area is able to produce complex visual hallucinations and is associated 
with auditory hallucinations in schizophrenic patients [66].   
 
Effects of propofol on subcortical areas 
A recent study by Sun et al. looked at changes in cerebral glucose metabolism 
using PET at two different doses of propofol.  Whole brain glucose metabolism was 
reduced in the cortical areas at the lower dose (1.5 µg/ml), but also occurred in the 
subcortical areas with the higher dose of propofol (2.5 µg/ml) [67].  This is consistent 
with previous propofol studies reporting decreased activity in the cortical area more than 
in subcortical areas [14, 67].  We found similar results, with propofol having a greater 
effect on cortical areas.  In terms of subcortical regions, we observed a decrease in rCBF 
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in the right lentiform nucleus and right thalamus, including the medial dorsal nucleus, 
with 0.5 MAC equivalent propofol.  The lentiform nucleus encompasses the putamen and 
globus pallidus in the basal ganglia, which plays an important role in regulating 
movement on a minute-to-minute basis.   
 
Effects of propofol on the thalamus 
The thalamus is typically thought to serve as the relay station of the brain, 
processing sensory information and relaying it to different parts of the brain.  In addition, 
it plays a critical role in the maintenance of consciousness and in regulating the sleep and 
wakeful states, suggesting that thalamic deactivation may play a central role in 
anesthesia-induced loss of consciousness [23, 68].  It is important to note that while we 
observed a decrease in rCBF in both the right and left thalamus, the decrease was only 
significant on the right (Figure 6). 
Numerous previous studies investigating the effects of propofol on rCBF have 
also shown a dramatic reduction in blood flow to the thalamus under anesthesia [3, 18, 
65, 69].  Electrophysiological studies looking at thalamocortical interactions have found 
them to be decreased in natural sleep as well as under anesthesia [23].  The medial dorsal 
nucleus of the thalamus, which plays a role in memory, attention, planning, and receives 
dense inputs from the prefrontal cortex and limbic system, has also been found to be 
preferentially sensitive to the effects of propofol, as was found in the present study [69].  
In addition, these previous studies too have noted that the effects of propofol 
preferentially decreases rCBF in the right thalamus in comparison to the left, but the 
significance of this remains unknown [23, 65, 69].  It has been suggested that decreases 
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in rCBF to the thalamus may be due to the decreased activity of the cortex under 
anesthesia, thus decreasing corticothalamic inputs, and we cannot rule this out as a 
contributing factor [69].   
 
Comparison of effects of sevoflurane and propofol 
With 0.5 MAC sevoflurane anesthesia, there was also a non-uniformity in rCBF, 
as has previously been seen with 0.25 MAC sevoflurane [70].  Regions manifesting a rise 
in rCBF include the superior temporal gyrus, middle temporal gyrus, lingual gyrus, 
parahippocampal gyrus, anterior cingulate, cingulate gyrus, claustrum, insula, and pons. 
Regions manifesting a decrease in rCBF with sevoflurane anesthesia include areas within 
the frontal, parietal, temporal, and occipital lobes, as well as the anterior cingulate, 
cingulate gyrus, lentiform nucleus, thalamus, and cerebellum.  
 
Frontal lobe 
 In terms of the frontal lobe, both propofol and sevoflurane caused a decrease in 
rCBF in many areas modulating higher order mental functions, including the middle 
frontal gyrus, medial frontal gyrus, and subcallosal gyrus, indicating that these regions 
may play a critical role in the action of anesthetic agents.  Given the role these regions 
play in the storage and processing of working memory, as well as in executive function, 
perhaps suppressing the action of these areas helps to induce the amnesic effects of 
anesthesia.  
 
Parieto-occipito lobe 
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 Both sevoflurane and propofol also caused a decrease in rCBF to the inferior 
parietal lobule and the cuneus area, but sevoflurane did not lead to a decrease in rCBF in 
the precuneus.  Thus, perhaps the precuneus area is specifically targeted by propofol and 
contributes to a decreased level of consciousness and arousal experienced with the 
anesthetic agent.  The occipital lobe does have a higher concentration of GABA receptors 
compared to other areas of the brain, which may help explain why propofol causes a 
decrease in rCBF but sevoflurane does not.  Further studies looking at the action of 
propofol in this area using various receptor ligands are needed to better understand the 
molecular mechanism of its action in this area. 
 
Temporal lobe 
 In the temporal lobe, sevoflurane caused both an increase and decrease in rCBF in 
different voxels of the superior temporal gyrus, and led to an increase in rCBF in the 
middle temporal gyrus.  This is the opposite of that seen with propofol, which led to 
suppression of the language processing area in the superior temporal gyrus and 
suppression of the middle temporal gyrus, which is important in recognition of known 
faces. 
 
Thalamus 
 Sevoflurane and propofol both led to a decrease in rCBF in the thalamus, though 
with sevoflurane this occurred bilaterally rather than unilaterally on the right.  This 
reaffirms that the thalamus is a critical site of action for anesthetic agents and is not 
specific to propofol.  Decreased activity within the thalamus as well as the above 
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mentioned cortical areas, including regions of the temporal lobe, the inferior parietal 
lobule, and the inferior and middle frontal gyri, have also been identified in association 
with the decreased level of consciousness seen in sleep and coma [71, 72, 73].  Clinically, 
our subjects in both studies were asleep with OAA/S scores of 3/5 or less, and they did 
not have any memory of the events during the anesthesia cycle.  However, no specific 
memory test was carried out.   
 
Limbic lobe 
In addition, both sevoflurane and propofol led to an increase in rCBF in the 
parahippocampal gyrus in the limbic lobe, the significance of which must be further 
investigated.  Whereas propofol led to a decrease in rCBF in the posterior cingulate, 
sevoflurane led to a decrease in rCBF in the anterior cingulate and cingulate gyrus.  This 
indicates that both agents suppressed areas within the limbic lobe, though their exact 
targets differed.  Whereas the posterior cingulate (main nodal region for default mode 
network) plays an important role in conscious information processing, the anterior 
cingulate has important autonomic functions, including regulating blood pressure and 
heart rate, as well as pain processing and modulation.  This may explain why we 
observed a greater drop in blood pressure and heart rate with sevoflurane anesthesia in 
comparison to propofol [21, 23].  Nonetheless, further studies are needed in order to 
justify such an assumption.   
 
Cerebellum 
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One region that was seemingly unaffected with propofol but had a significant 
decrease in rCBF with sevoflurane was the cerebellum, which is involved in motor 
control and coordination.  Multiple voxels within both the right and left cerebellum were 
suppressed with sevoflurane, which may contribute to the decreased muscle tone 
observed under anesthesia.  In contrast, a PET study looking at the effects of propofol on 
the CNS found an increase in rCBF in the cerebellum, which was attributed to the initial 
increase in muscle tone and jerking movements seen during the early states of propofol 
anesthesia [23].  However, we did not observe these changes with propofol.  Another 
PET study found the cerebellum to be easily suppressed by both sevoflurane and 
propofol, indicating the need for further studies to better understand the effects of 
anesthesia on this region [74]. 
 
PASL Technique 
Although studies have been done looking at the cerebral effects of propofol using 
PET and EEG, this is the first study to our knowledge using PASL cerebral perfusion 
technique to investigate the effects of propofol anesthesia on the human brain.  In order to 
best interpret our results, it is imperative to understand the biophysical mechanisms of 
perfusion imaging using pulsed arterial spin labeling (PASL) and its advantages and 
disadvantages in assessing the effects of propofol and sevoflurane on cerebral blood flow.  
As stated previously, in the PASL technique, instead of using an extrinsic tracer, a RF 
pulse sequence is applied to the arterial water spins.  By adding the inversion delay, these 
inverted arterial spins are allowed time to diffuse through the blood-brain barrier, where 
they are exchanged with the tissue magnetization at the capillary level, reducing its 
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intensity.  The degree to which the spin is attenuated serves as a measure of perfusion to 
that region [32].   
The benefit of this technique is that it is completely noninvasive, does not require 
injection of contrast, and has a very high spatial and temporal resolution.  In addition, it is 
more accurate at localizing regions of activation, since it is concerned with activity at the 
capillary level, and not affected by the change in deoxygenated blood in the downstream 
venous areas as in BOLD [75].  However, some argue that there could be possible 
confounding factors secondary to changes in physiologic variables caused by the 
anesthetic agent [59].  For instance, changes in systemic arterial blood pressure with 
propofol and sevoflurane could decrease CBF.  However, studies have shown that 
changes in blood pressure do not affect CBF so long as the mean arterial pressure is 
within the autoregulatory range and autoregulation is intact, which is the case for the 0.5 
MAC levels of anesthesia used in this study [23, 59].  As shown in Table 2, all 
physiological parameters (MAP, ETCO2, SpO2, HR) were within normal limits during the 
study. 
Under normal circumstances in which the MAP between 60 and 150 mmHg, the 
average cerebral blood flow is relatively constant due to protective autoregulation.  
Within this range, a fall in cerebral perfusion would lead to vasodilation of the cerebral 
resistance vessels within seconds, and thus an increase in cerebral blood flow.  In 
contrast, an increase in cerebral perfusion would lead to vasoconstriction, causing an 
immediate decrease in cerebral blood flow.  As stated above, the MAP at baseline for all 
subjects was 79 ± 8 mmHg, while under anesthesia is was 71 ± 8 mmHg.  Both values 
fall within the autoregulatory range.  In addition, there was no significant difference in 
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the subjects’ SpO2, end tidal CO2, and heart rate before and after anesthesia was 
administered.  Thus, the observed changes in rCBF can justifiably be attributed to 
changes in metabolic activity rather than changes in systemic blood pressure.   
It has also been argued that sevoflurane is known to have direct cerebral 
vasodilatory effects, which could alter the rCBF [76].  While this cannot be excluded as a 
contributing factor, we assume that it only minimally impacts the large changes in rCBF 
observed in our study and that the net direction of change in rCBF is accurate.  Marcar et 
al. (2006) used fMRI to study the depth of anesthesia on the extent and amplitude of the 
BOLD response in children, and found that up to 0.5 MAC sevoflurane, vasodilation was 
not significant [77].  However, beyond 1.0 MAC sevoflurane, vasodilation did become 
significant [77].  In addition, vasoactive changes would affect global circulation rather 
than flow in particular regions, thereby lessening any impact on the relative changes 
observed [23].   Such changes do not occur with propofol, and any changes in rCBF 
observed can be taken as a direct reflection of changes in neuronal activity induced by the 
anesthetic agent. 
 
Limitations 
 One limitation of our study is that we did not look at the concentration dependent 
effects on the brain, as has previously done with PET imaging [17, 23].  The effects 
observed in our study were obtained at a single and equivalent dose level of propofol and 
sevoflurane.  Thus, we are not able to determine if certain areas affected by these 
anesthetic agents are more susceptible to the effects of anesthesia, nor the sequence in 
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which various cortical and subcortical structures are suppressed.  Further studies looking 
at the concentration dependent effects on rCBF using PASL are needed. 
 A second limitation of our study is that we did not use any task activation to 
specifically look at the effects of 0.5 MAC propofol or sevoflurane on a targeted area, 
such as the visual, auditory, or motor cortex.  In order to better determine the extent to 
which a certain region of the brain is affected by anesthesia, it would be more accurate to 
measure δCBF during task activation in both the awake and anesthetized states and then 
look at the difference between the two.  By studying both the changes in rCBF with 
different types of task activation and with various doses of anesthesia, we would be able 
to more completely understand the anesthetic effects of propofol and sevoflurane on 
neuronal activity.  Nevertheless, our study lays a strong foundation by identifying various 
regions in the brain that are significantly altered from baseline with propofol and 
sevoflurane, and that may be further investigated in future studies using different doses 
and task activation.  
 A third limitation of our study is that we did not measure metabolism, which 
would confirm that the CBF changes we observed do truly reflect changes in neuronal 
activity.  However, given that propofol does not have significant vasodilatory effects, the 
rCBF changes we observed can be taken as a direct reflection of change in neuronal 
activity. 
 
Conclusions 
 In summary, this study provides direct imaging evidence showing that propofol 
preferentially decreases regional cerebral blood flow in a specific set of cortical regions 
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and the thalamus, similar to those observed with sevoflurane.  The loss of consciousness 
observed with these agents likely correlates with deactivation of the thalamus, though 
effects on cognitive process involving areas of the frontal, parietal, and temporal lobes 
likely contribute to this effect.  Given that both propofol and sevoflurane potentiate the 
effects of GABA at the receptor level, areas with a higher concentration of such synapses 
are expected to be more sensitive to the effects of these anesthetic agents [3, 33].  This 
may help explain why propofol and sevoflurane preferentially affect these higher 
processing regions of the brain with more corticocortical connections.  However, further 
studies are needed to understand the mechanism of loss of consciousness induced by 
propofol and sevoflurane, and to determine if the above mentioned cortical areas are 
directly or indirectly involved in the process. 
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